Does CABOZANTINIB Cause Metastasis? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Metastasis have been filed in association with CABOZANTINIB. This represents 0.2% of all adverse event reports for CABOZANTINIB.
6
Reports of Metastasis with CABOZANTINIB
0.2%
of all CABOZANTINIB reports
1
Deaths
4
Hospitalizations
How Dangerous Is Metastasis From CABOZANTINIB?
Of the 6 reports, 1 (16.7%) resulted in death, 4 (66.7%) required hospitalization.
Is Metastasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB Cause?
Diarrhoea (404)
Fatigue (263)
Malignant neoplasm progression (238)
Nausea (215)
Decreased appetite (191)
Off label use (190)
Hypertension (165)
Pyrexia (162)
Vomiting (157)
Asthenia (153)
What Other Drugs Cause Metastasis?
RIBOCICLIB (404)
LETROZOLE (284)
TRASTUZUMAB (273)
CYCLOPHOSPHAMIDE (267)
FULVESTRANT (262)
CAPECITABINE (233)
BEVACIZUMAB (225)
CARBOPLATIN (206)
LEUPROLIDE (201)
PACLITAXEL (198)
Which CABOZANTINIB Alternatives Have Lower Metastasis Risk?
CABOZANTINIB vs CABOZANTINIB S-MALATE
CABOZANTINIB vs CAFFEINE
CABOZANTINIB vs CALASPARGASE PEGOL
CABOZANTINIB vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB vs CALCIFEDIOL